Article Details
Retrieved on: 2025-04-10 17:36:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA has granted full approval to Vitrakvi (larotrectinib) for the treatment of solid tumors that have a neurotrophic receptor tyrosine kinase ...
Article found on: www.empr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here